Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Current Research in Parasitology & Vector-Borne Diseases|February 25, 2025
Insights into the transmission cycle of cutaneous leishmaniasis from an endemic community in rural GuatemalaYaimie Lopez, Aitor Casas-Sanchez, Byron Arana, et al.
Bulletin of the World Health Organization|September 5, 2007
Pneumonia case-finding in the RESPIRE Guatemala indoor air pollution trial: standardizing methods for resource-poor settingsNigel Bruce, Martin Weber, Byron Arana, et al.
The American Journal of Tropical Medicine and Hygiene|December 19, 2006
The reliability of anterior segment lesions as indicators of onchocercal eye disease in GuatemalaKevin L Winthrop, Roberto Proaño, Orlando Oliva, et al.
The American Journal of Tropical Medicine and Hygiene|November 7, 2007
No depletion of Wolbachia from Onchocerca volvulus after a short course of rifampin and/or azithromycinFrank O Richards, Josef Amann, Byron Arana, et al.
Plos Neglected Tropical Diseases|February 21, 2024
Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile developmentMaría Del Mar Castro, Astrid C Erber, Byron Arana, et al.
British Journal of Clinical Pharmacology|November 20, 2025
Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participantsJean-Yves Gillon, Sophie Delhomme, Delphine Launay, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 7, 2010
Ambisome plus miltefosine for Indian patients with kala-azarShyam Sundar, Prabhat Kumar Sinha, Deepak K Verma, et al.
Plos Neglected Tropical Diseases|February 29, 2020
CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasisSeth G Thacker, Ian L McWilliams, Beatrice Bonnet, et al.
International Journal for Parasitology. Drugs and Drug Resistance|July 20, 2019
Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasisDiana Caridha, Brian Vesely, Katrien van Bocxlaer, et al.
Tropical Medicine & International Health : TM & IH|November 10, 2012
Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trialShyam Sundar, Prabat Sinha, T K Jha, et al.
Pageof 5